Key result
MgATP-dependent actin filament velocity was hyperbolic with a maximum of 0.6 micron/s, while MgADP and inorganic phosphate competitively inhibited actin movement.
The in vitro motility assay accurately models smooth muscle contraction, demonstrating that MgADP and Pi competitively inhibit MgATP-dependent actin movement.
Should not change practice; extends kinetic models of smooth muscle myosin but leaves translation open.
To test the idea that the in vitro motility assay is a simplified model system for muscle contraction, the MgATP-dependent movement of actin filaments by thiophosphorylated smooth muscle myosin was characterized in the presence of the products MgADP and inorganic phosphate. The dependence of actin filament velocity on MgATP concentration was hyperbolic with a maximum velocity of 0.6 micron/s and an apparent Km = 40 microM (30 degrees C). MgADP competitively inhibited actin movement by MgATP with a Ki = 0.25 mM. Inorganic phosphate did not affect actin filament velocity in the presence of 1 mM MgATP, but competitively inhibited movement in the presence of 50 microM MgATP with a Ki = 9.5 mM. The effects of ADP and Pi on velocity agree with fiber mechanical studies, confirming that the motility assay is an excellent system to investigate the molecular mechanisms of force generation and shortening in smooth muscle. The rate at which rigor cross-bridges can be recruited to move actin filaments was observed by initiating cross-bridge cycling from rigor by flash photolysis of caged MgATP. Following the flash, which results in a rapid increase in MgATP concentration, actin filaments experienced a MgATP-dependent delay prior to achieving steady state velocity. The delay at low MgATP concentrations was interpreted as evidence that motion generating cross-bridges are slowed by a load due to a transiently high percentage of rigor cross-bridges immediately following MgATP release.
No takes yet. Share an insight, caveat, or question.
Warshaw et al. (1991) studied this question. MgATP, MgADP, and Pi was evaluated on Actin filament velocity. MgATP-dependent actin filament velocity was hyperbolic with a maximum of 0.6 micron/s, while MgADP and inorganic phosphate competitively inhibited actin movement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: